Armelle Laurand

<i>ERCC5</i>/<i>XPG</i>, <i>ERCC1,</i> and <i>BRCA1</i> gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma

Antoîne Italiano, Armelle Laurand, Audrey Laroche et al. · Cancer · 2011 · 65 citations

Life Sciences, Genetics, Oncology +17

Determination of <i>ERCC2</i> Lys751Gln and <i>GSTP1</i> Ile105Val Gene Polymorphisms In Colorectal Cancer Patients: Relationships with Treatment Outcome

Valérie Le Morvan, Denis Smith, Armelle Laurand et al. · Pharmacogenomics · 2007 · 61 citations

Medicine, Molecular Genetics, Oncology +16

Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients

Elisabeth Rouits, Virginie Charasson, Aurélie Pétain et al. · British Journal of Cancer · 2008 · 56 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Functional study of the 830C&gt;G polymorphism of the human carboxylesterase 2 gene

Ricardo Bellott, Valérie Le Morvan, Virginie Charasson et al. · Cancer Chemotherapy and Pharmacology · 2007 · 24 citations

Life Sciences, Genetics, Molecular Genetics +5

Quantification of the expression of multidrug resistance-related genes in human tumour cell lines grown with free doxorubicin or doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres.

Armelle Laurand, Audrey Laroche‐Clary, Annick Larrue et al. · PubMed · 2005 · 23 citations

Medicine, Oncology, Pharmacology +16